Beckman Coulter Diagnostics improves patient care with synergistic immunoassay and microbiology solutions
12 Jun 2024

Beckman Coulter Immunoassay and Beckman Coulter Microbiology have joined forces at ESCMID Global to introduce the DxI 9000 Immunoassay Analyzer where the company launched a brand-new suite of blood virus assays to the public. This new suite of assays complements the Microbiology portfolio to provide mechanisms for early detection and confirmation of bacterial and viral infections to improve patient outcomes. Discover how Beckman Coulter Diagnostics is transforming the landscape of diagnostic testing, offering a patient-centric approach with unprecedented accuracy, efficiency, and reliability.
This video was filmed at ESCMID Global 2024.
About the company

Beckman Coulter Diagnostics
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company s 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.






















